在高血糖引起的血管损伤中,ZIPK与STAT5A在p53介导的ROS积累中合作
Qichao Wu1,2,3, Tingting Xie1,2, Chang Fu4,5
1Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai 200031, China.
Acta biochimica et biophysica Sinica
|July 20, 2024
概括
拉链相互作用蛋白激酶 (ZIPK) 通过激活STAT5A来驱动高葡萄糖的血管损伤,导致p53和NOS2的增加. 抑制ZIPK可以治疗糖尿病血管并发症.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 血管生物学 血管生物学
背景情况:
- 高血糖水平导致血管损伤,这是糖尿病的一个关键并发症.
- 在这个过程中,ZIPK (Zipper-interacting protein kinase) 的作用尚未完全被理解.
- 了解高葡萄糖诱导的血管损伤所涉及的分子通路对于开发有效的治疗方法至关重要.
研究的目的:
- 调查ZIPK在高葡萄糖诱导的血管损伤中的作用.
- 阐明ZIPK,STAT5A,p53和可诱导的氧化合成酶 (NOS2) 之间的相互作用.
- 评估ZIPK作为糖尿病血管并发症的潜在治疗点.
主要方法:
- 人类静脉内皮细胞 (HUVEC) 在正常和高葡萄糖条件下培养.
- 使用遗传工具 (过度表达,siRNA,shRNA) 来操纵ZIPK和STAT5A的表达.
- 评估了蛋白质和基因表达,ROS水平和细胞损伤;使用糖尿病老鼠模型测试ZIPK抑制剂.
主要成果:
- 高葡萄糖上调ZIPK,STAT5A,p53和NOS2,增加了氧化应激 (ROS).
- STAT5A和ZIPK对于高葡萄糖诱导的p53表达和ROS积累至关重要.
- 在高葡萄糖下,ZIPK和STAT5A在核中直接相互作用.
- 在糖尿病大鼠中,ZIPK抑制降低了血管损伤标志物.
结论:
- 通过STAT5A介导的途径,ZIPK在高葡萄糖诱导的血管损伤中发挥着关键作用.
- 准ZIPK可能为治疗糖尿病血管并发症提供一种新的治疗策略.
- ZIPK-STAT5A-p53-NOS2轴是糖尿病血管损伤的一个关键途径.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K


